P21.07 Immune-Related Adverse Events with Durvalumab Consolidation in a Real-World Cohort of Patients with Non–Small Cell Lung Cancer (NSCLC)
| Autor: | Montenegro, G. Bravo, Serzan, M., Belouali, A., Sackstein, P., Chen, K., Rao, S., Veytsman, I., Madhavan, S., Liu, S., Kim, C. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology March 2021 16(3) Supplement:S366-S366 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|